Mepolizumab (Synonyms: SB 240563) |
| Catalog No.GC66347 |
Mepolizumab (SB 240563) es un anticuerpo monoclonal humanizado que se une y neutraliza la interleucina-5 (IL-5), la principal citocina involucrada en la proliferaciÓn, activaciÓn y supervivencia de los eosinÓfilos. Mepolizumab se puede utilizar para la investigaciÓn de la granulomatosis eosinofÍlica con poliangitis (EGPA) y el asma eosinofÍlica grave.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 196078-29-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma[1][2].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *